Thermo Scientific - Pierce Protein Research Products
Part of Thermo Fisher Scientific  

Slide-A-Lyzer MINI Dialysis Applications Guide (cont.) 
 

(back to main)


Sample Concentration
  1. Add ~1.3 ml concentrating solution (Product # 66526) to a microfuge (Product # 69715)
  2. Add sample to a MINI unit and place membrane in contact with the concentrating solution in the microtube; cap the microtube; use at least 3:1 ratio of concentrating solution to sample.
  3. The sample will concentrate at 35-45 µl/hour

MINI Unit in microtube for concentration.
(back to top)  (back to main)

Dialysis Time Small Compound

We evaluated the dialysis rate per time of several other compounds in 3.5K, 7K and 10K Slide-A-Lyzer MINI Dialysis Units. A starting volume of 100 µl of 2 mg/ml ATP (Sigma, M.W. 551), 1 mg/ml Sulfo-NHS-Biotin (M.W. 556), 5 mg/ml bacitracin (Sigma, M.W. 1.4 kD) or 0.5 mg/ml vitamin B12 was dialyzed against 1 liter of water or TBS, pH 7.2. Samples of 5-10 µl were withdrawn from the Slide-A-Lyzer MINI Dialysis Unit at various time intervals to evaluate the dialysis process. Overnight dialysis samples remained undisturbed. ATP was monitored by A240 (Figure 5). Vitamin B12 was measured by A360 (Figure 6). Bacitracin was measured at A562 following BCA Assay (Figure 7). Biotin was determined using Wallac's Victor Microplate Reader and 2-anilinonaphthalene-6- sulfonic acid (Molecular Probes) assay. After overnight dialysis, ~1.3%, 0.8% and 0.2% biotin remained for the 3.5K, 7K and 10K Slide-A-Lyzer MINI Dialysis Units, respectively.



Figure 5. Dialysis time course for 100 µl of 2 mg/ml ATP.



Figure 6. Dialysis time course for 100 µl of vitamin B12.



Figure 7. Dialysis time course for 100 µl of bacitracin.

(back to top)  (back to main)

Scavenger Dialysis using the Slide-A-Lyzer MINI Unit

Scavenger dialysis can be used to selectively remove unwanted components of smaller molecular weight from a protein sample. The scavenger system has the following advantages:

  1. The protein never contacts the scavenger matrix
  2. No buffer changes are required~less hands-on time
  3. Less dialysate buffer is required
  4. Dialysis rates are improved by uptake of the unwanted component

Scavenger Dialysis:


Resin/Media Selection Guide:
Method Resin/Media Mobile Phase Sample Characteristic

Reverse Phase

(Partitioning)

C18, C8, C2, cyclohexyl

(longer chain alkanes)

Aqueous/Organic

Note: addition of 0.1% TFA opens most proteins (peptides and amino acids) exposing hydrophobic regions allowing binding to the RP adsorbent.

Non-polar samples are retained and eluted with non-polar solvents

Normal Phase

Silica, Diol, NH2, CN

Mix of Organic Solvents

Polar samples are retained then eluted with polar solvents.

Hydrophobic

Adsorbtion

Similar to reverse phase, much less hydrophobic

(charcoal)

Salt Solution

Proteins

Ion-Pair

C8, C18, CN

Aqueous organic buffer to control pH of ion-pair reagent

Proteins

Samples associate with other compounds so their retention behavior is altered.

Ion-Exchange

Anion, Cation

(Silica, Alumina, Dowex, etc)

*see anion cation exchangers listed below

Aqueous buffer with varied pH and ionic strength

Organic ions, proteins, nucleic acids

Binds samples of opposite charge

Affinity

Various (table X)

Various

Various

Chiral

Cyclodextran

 

Separation of left and right hand compounds (enantiomers)


Ion-Exchangers, Buffers and Uses

Anion Exchangers:

DEAE

Diethylaminoethyl-

6-9.5

TEAE

Triethylaminoethyl-

NA

QAE

Trimethylaminoethyl- or other quartenary amines

NA

P

Ampholytic polymers

Complete pH range


Cation Exchangers:

CM

Carboxymethyl-

3.5-5.0

P

Phospho-

5.5-7.5

SP

Sulphopropyl-

NA

S

Sulphoethyl-

NA


Ion-Exchange Buffers:

Cation Exchange

Acetate

pH 5

 

MES

pH 6

 

MOPS

pH 7

 

Histidine

pH 6

Anion Exchange

Diethanolamine

pH 9

 

Tris

pH 8

 

Imidazole

pH 7

 

Histidine

pH 6



Ion-Exchanger Used for Purification/Removal:
Alumina Silica Charcoal Dowex
Alkaloids Phospholipase A Dyes Inositol Phosphates
Antibiotics Nucleic acids GTP from P Phospholipase D
Oils
Drugs
Plant extraction
Organic solvents
Gycosides
Hormones
Peroxides
Pyrogens
Steroids
Vitamins
Phosphates*
*phosphate containing proteins, nucleotides, peptides

Pierce Affinity Resins:

Antibody fc region

Protein A, G, A/G, T-gel™ Absorbent, Ni-IDA

Antibody light chain (k)

Protein L

Carbohydrate

Lectins

Biotin

Streptavidin, Avidin, NeutrAvidin™ Protein

Histidine, (phosphate)

Nickel Activated Imminodiacetic Acid, (Iron)

GST fusion

Glutathione

Endotoxin Remover

Detoxi-Gel™

Detergent Removal

Extracti-Gel Gel (OTG, CHAPS, SDS, Triton X, Tween 20, lysis buffers*)


Scavenger Dialysis Application:

Scavenger removal of fluorescent dye from fluorescent conjugated his-tag and his-region proteins using the Slide-A-Lyzer MINI Unit

Activated fluorescent reagent was covalently coupled to the 6his-tag of a fusion protein in A) lysate and B) purified form. The activated fluorescent reagent was also covalently conjugated to the C) his-region of an antibody. After conjugation, the fluorescent conjugates (100 µl of 0.1 mg/ml 6his-uricase or 0.5 mg/ml GtaRb antibody) were placed in 10K SAL MINI Units. The SAL MINIs were then placed in a microtube containing ~30 mg of acidic alumina and ~1.3 ml TBS. The MINI in the microtube was capped and left standing overnight at RT. All unconjugated dye was bound to the alumina resin at the bottom of the microtube. The conjugates were removed from the MINI, diluted then electrophoresed on a Novex 10% Bis-Tris (MES) gel. After electrophoresis, the gel was placed briefly in a clearing buffer and then imaged with CCD camera.


(back to top)  (back to main)


Equilibrium Dialysis using the Slide-A-Lyzer MINI Unit

Equilibrium dialysis can be accomplished using the Slide-A-Lyzer MINI Unit and 48-well microplates. The Slide-A-Lyzer MINI holds a maximum volume of 0.5 ml. The well volume for the 48-well microplates are 0.3-0.6 ml (0.3-0.5 ml Costar #3548, & 0.4-0.5 ml Falcon #1178).


*Packard's Fusion™ Universal Microplate Analyzer has 48-well plate read capability.


Books

Protein-Ligand Interactions A Practical Approach
Volume 1: Hydrodynamics and Calorimetry Edited by S.E. Harding and Babur Chowdhry
Chapter 2. Equilibrium dialysis and rate dialysis, Bent Honoré

Journal References

  1. Sarmiento, F., et al. (2000). The interaction between catalase and nafcilin by equilibrium dialysis measurements. Eur. Biophys. J. 29(4-5), 277.
  2. Plum, A., et al. (1999). Determination of in vitro plasma protein binding of insulin aspart and insulin detemir by equilibrium dialysis. Diabetologia 42(1) A236.
  3. Karim, S., et al. (1998). The effect of hyaluronan on the binding of diclofenac to human albumin using equilibrium dialysis. J. Pharm. Pharmacol. 50(1), 197.
  4. Kiehr, B., et al. (1998). Plasma protein binding: An iterative approach of performing equilibrium dialysis. Experimental and Toxicologic Pathology 50(2), 114-115.
  5. Ottiger, C. and Wunderli-Allenspach, H. (1997). Partition behaviour of acids and bases in a phosphatidylcholine liposome-buffer equilibrium dialysis system. European J. Pharm. Sci. 5(4), 223-231.
  6. Alexandre, H, et al. (1997). Interactions between toxic fatty acids for yeasts and colloids, cellulose and yeast ghost using the equilibrium dialysis method in a model wine. Food Biotechnol. 11(1), 89-99.
  7. Creutz, C. (1996). Equilibrium dialysis experiment: An interactive stimulation. American Journal of Botany 83(6), 214.
  8. Wilson, B. and Lindahl, P. (1999). Equilibrium dialysis study and mechanistic implications of coenzyme A binding to acetyl-CoA synthase/carbon monoxide dehydrogenase from Clostridium thermoaceticum. J. Biol. Inorg. Chem. 4(6), 742-8.
  9. Chattoraj, D. et al. (1999). Standard free energies of binding of solute to proteins in aqueous medium. Part 2. Analysis of data obtained from equilibrium dialysis and isopiestic experiments. Biophys. Chem. 77(1) 9-25.
  10. Chow, H., et al. (1998). A modified equilibrium dialysis technique for measuring plasma protein binding: experimental evaluation with diazepam and nortriptyline. Pharm. Res. 15(10), 1643-6.
  11. Sinha-Hikim, I., et al. (1998). The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J. Clin. Endocrinol. Metab. 83(4), 1312-8.
  12. Okabayashi, T., et al. (1996). Free thyroxine concentrations in serum measured by equilibrium dialysis in chronic renal failure. Clin. Chem. 42(10), 1616-20.
  13. Bizouarn, T., et al. (1996). The binding of nucleotides to domain I proteins of the proton-translocating transhydrogenases from Rhodospirillum rubrum and Escherichia coli as measured by equilibrium dialysis. Eur. J. Biochem. 239(3), 737-41.
  14. Jaume, J. (1996). Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artifactual elevations in the serum-free thyroxine concentration as measured by equilibrium dialysis. Thyroid 6(2), 79-83.
  15. Girard, I. and Ferry, S. (1996). Protein binding of methohexital. Study of parameters and modulating factors using the equilibrium dialysis technique. J. Pharmaceut. Biomed. Anal. 14(5), 583-91.
(back to top)  (back to main)
 



Learn more about other Thermo Scientific Life Science Research Products

Biopolymers Cell Culture High Content Screening  
Nucleic Acid Technologies PCR Reagents & Plastics RNAi Technologies  European Sales



 © 2010 Thermo Fisher Scientific Inc.

PO Box 117, Rockford, IL 61105 USA 1-800-874-3723         815-968-0747